Point of Care Infectious Disease Testing Market Size, Share, and Outlook, 2025 Report- By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu

Point of Care Infectious Disease Testing Market Outlook

Point of Care Infectious Disease Testing Market Size is forecast to register an optimistic growth rate of 10.7% from 2025 to 2032.. The Point of Care Infectious Disease Testing market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain.

The comprehensive market research report presents 12-year historic and forecast data on Point of Care Infectious Disease Testing segments across 22 countries from 2021 to 2032. Key segments in the report include By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others). Over 70 tables and charts showcase findings from our latest survey report on Point of Care Infectious Disease Testing markets.

Point of Care Infectious Disease Testing Market Insights, 2025

The point of care infectious disease testing market is experiencing significant growth due to the rising need for rapid detection and diagnosis of infectious diseases. These tests provide quick results at the patient's location, making them essential in controlling the spread of infections and enabling prompt treatment. The market is driven by the increasing prevalence of infectious diseases, including COVID-19, influenza, and sexually transmitted infections, as well as the growing demand for decentralized healthcare solutions. With advancements in diagnostic technologies, the point of care infectious disease testing market is poised for continued expansion.

Five Trends that will define global Point of Care Infectious Disease Testing market in 2025 and Beyond

A closer look at the multi-million global market for Point of Care Infectious Disease Testing identifies rapidly shifting consumer preferences across categories. By focusing on growth and resilience, leading Point of Care Infectious Disease Testing companies are prioritizing their investments across categories, markets, and geographies. The report analyses the most important market trends shaping the new landscape to support better decisions for the long and short-term future.

What are the biggest opportunities for growth in the Point of Care Infectious Disease Testing industry?

The Point of Care Infectious Disease Testing sector demonstrated remarkable resilience over the past year across developed and developing economies. Further, the market presents significant opportunities to leverage the existing momentum towards actions by 2030. On the other hand, recent macroeconomic developments including rising inflation and supply chain disruptions are putting pressure on companies. The chapter assists users to identify growth avenues and address business challenges to make informed commercial decisions with unique insights, data forecasts, and in-depth market analyses.

Point of Care Infectious Disease Testing Market Segment Insights

The Point of Care Infectious Disease Testing industry presents strong offers across categories. The analytical report offers forecasts of Point of Care Infectious Disease Testing industry performance across segments and countries. Key segments in the industry include- By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others). The largest types, applications, and sales channels, fastest growing segments, and the key factors driving each of the categories are included in the report.

Forecasts of each segment across five regions are provided from 2021 through 2032 for Asia Pacific, North America, Europe, South America, Middle East, and African regions. In addition, Point of Care Infectious Disease Testing market size outlook is provided for 22 countries across these regions.

Market Value Chain

The chapter identifies potential companies and their operations across the global Point of Care Infectious Disease Testing industry ecosystem. It assists decision-makers in evaluating global Point of Care Infectious Disease Testing market fundamentals, market dynamics, and disruptive trends across the value chain segments.

Scenario Analysis and Forecasts

Strategic decision-making in the Point of Care Infectious Disease Testing industry is multi-faceted with the increased need for planning across scenarios. The report provides forecasts across three case scenarios- low growth, reference case, and high growth cases.

Asia Pacific Point of Care Infectious Disease Testing Market Analysis- A Promising Growth Arena for Business Expansion

As companies increasingly expand across promising Asia Pacific markets with a combined population of over 4.5 billion, the medium-to-long-term future remains robust. The presence of the fastest-growing economies such as China, India, Thailand, Indonesia, and Vietnam coupled with strengthening middle-class populations and rising disposable incomes drive the market. In particular, China and India are witnessing rapid shifts in consumer purchasing behavior. China is recovering steadily with optimistic forecasts for 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.

The State of Europe Point of Care Infectious Disease Testing Industry 2025- Focus on Accelerating Competitiveness

As companies opt for an integrated agenda for competitiveness, the year 2025 presents optimistic scenarios for companies across the ecosystem. With signs of economic recovery across markets, companies are increasing their investments. Europe is one of the largest markets for Point of Care Infectious Disease Testing with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. Increasing omnichannel shopping amidst robust consumer demand for value purchases shapes the market outlook. The report analyses the key Point of Care Infectious Disease Testing market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.

The US Point of Care Infectious Disease Testing market Insights- Executives are most excited about opportunities for the US Point of Care Infectious Disease Testing industry.

Easing inflation coupled with strengthening consumer sentiment is encouraging aggressive actions from the US Point of Care Infectious Disease Testing companies. Market players consistently focusing on innovation and pursuing new ways to create value are set to excel in 2025. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Point of Care Infectious Disease Testing market.

Latin American Point of Care Infectious Disease Testing market outlook rebounds in line with economic growth.

Underlying demand remains higher among urban consumers with an optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries. Increased consumer spending has been reported since H2-2024 and the prospects remain strong for 2025. Aggressive ecosystem moves to create new sources of income are widely observed across markets in the region. Marketing activities focused on customer insights, operations, and support functions are quickly gaining business growth in the region.

Middle East and Africa Point of Care Infectious Disease Testing Markets- New Opportunities for Companies Harnessing Diversity

Rapid growth in burgeoning urban locations coupled with a young and fast-growing population base is attracting new investments in the Middle East and African Point of Care Infectious Disease Testing markets. Designing expansion and marketing strategies to cater to the local consumer base supports the market prospects. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies. On the other hand, Middle Eastern Point of Care Infectious Disease Testing markets including the UAE, Saudi Arabia, Qatar, and Oman continue to offer lucrative pockets of growth.

Competitive Landscape- How Point of Care Infectious Disease Testing companies outcompete in 2025?

The ability to respond quickly to evolving consumer preferences and adapt businesses to niche consumer segments remains a key growth factor. The report identifies the leading companies in the industry and provides their revenue for 2024. The market shares of each company are also included in the report. Further, business profiles, SWOT analysis, and financial analysis of each company are provided in detail. Key companies analyzed in the report include Alere, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Labs Inc, Cardinal Health, Chembio Diagnostics Inc, F. Hoffmann-La Roche Ltd, Gene POC, OJ-Bio Ltd, Ortho-Clinical Diagnostics, Quest Diagnostics Inc, Siemens Healthineers, Sight Diagnostics Ltd, Thermo Fisher Scientific Inc, Trinity Biotech, Trivitron Healthcare.

Reasons to Buy the report

  • Make informed decisions through long and short-term forecasts across 22 countries and segments.
  • Evaluate market fundamentals, dynamics, and disrupting trends set to shape 2025 and beyond.
  • Gain a clear understanding of the competitive landscape, with product portfolio and growth strategies.
  • Get an integrated understanding of the entire market ecosystem and companies.
  • Stay ahead of the competition through plans for growth in a changing environment for your geographic expansion.
  • Assess the impact of advanced technologies and identify growth opportunities based on actionable data and insights.
  • Get free Excel spreadsheet and PPT versions along with the report PDF.


1. Table of Contents
List of Figures and Tables
2. Executive Summary
2.1 Key Highlights
2.1.1 Point of Care Infectious Disease Testing Market Size Outlook, 2018-2024 and 2025-2032
2.1.2 Largest Point of Care Infectious Disease Testing Market Types and Applications
2.1.3 Fastest Growing Segments
2.1.4 Potential Markets
2.1.5 Market Concentration
2.2 Market Scope and Segmentation
2.2.1 Market Scope- Segments
2.2.2 Market Scope- Countries
2.2.3 Macroeconomic and Demographic Outlook
2.2.4 Abbreviations
2.2.5 Units and Currency Conversions
3. Research Methodology
3.1 Primary Research Surveys
3.2 Secondary Data Sources
3.3 Data Triangulation
3.4 Forecast Methodology
3.5 Assumptions and Limitations
4. Introduction to Global Point of Care Infectious Disease Testing Market in 2025
4.1 Industry Panorama
4.2 Leading Companies Profiled in the Study
4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
4.4 Market Dynamics
4.4.1 Market Dynamics- Trends and Drivers
4.4.2 Market Dynamics- Opportunities and Challenges
4.5 Regional Analysis
4.6 Porter’s Five Force Analysis
4.6.1 Intensity of Competitive Rivalry
4.6.2 Threat of New Entrants
4.6.3 Threat of Substitutes
4.6.4 Bargaining Power of Buyers
4.6.5 Bargaining Power of Suppliers
4.7 Point of Care Infectious Disease Testing Industry Value Chain Analysis
4.7.1 Stage of Value Chain
4.7.2 Key Activities of Companies
4.7.3 Companies Included in Each Stage
4.7.4 Key Insights
5. Point of Care Infectious Disease Testing Market Outlook to 2032
5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
By Disease
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Others
By End-user
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
6. Global Point of Care Infectious Disease Testing Market Outlook across Growth Scenarios
6.1 Low Growth Scenario
6.2 Base/Reference Case
6.3 High Growth Scenario
6. North America Point of Care Infectious Disease Testing Market Size Outlook
6.1 Key Market Statistics, 2024
6.2 North America Point of Care Infectious Disease Testing Market Trends and Growth Opportunities
6.2.1 North America Point of Care Infectious Disease Testing Market Outlook by Type
6.2.2 North America Point of Care Infectious Disease Testing Market Outlook by Application
6.3 North America Point of Care Infectious Disease Testing Market Outlook by Country
6.3.1 The US Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
6.3.2 Canada Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
6.3.3 Mexico Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
7. Europe Point of Care Infectious Disease Testing Market Size Outlook
7.1 Key Market Statistics, 2024
7.2 Europe Point of Care Infectious Disease Testing Market Trends and Growth Opportunities
7.2.1 Europe Point of Care Infectious Disease Testing Market Outlook by Type
7.2.2 Europe Point of Care Infectious Disease Testing Market Outlook by Application
7.3 Europe Point of Care Infectious Disease Testing Market Outlook by Country
7.3.2 Germany Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
7.3.3 France Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
7.3.4 The UK Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
7.3.5 Spain Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
7.3.6 Italy Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
7.3.7 Russia Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
7.3.8 Rest of Europe Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
8. Asia Pacific Point of Care Infectious Disease Testing Market Size Outlook
8.1 Key Market Statistics, 2024
8.2 Asia Pacific Point of Care Infectious Disease Testing Market Trends and Growth Opportunities
8.2.1 Asia Pacific Point of Care Infectious Disease Testing Market Outlook by Type
8.2.2 Asia Pacific Point of Care Infectious Disease Testing Market Outlook by Application
8.3 Asia Pacific Point of Care Infectious Disease Testing Market Outlook by Country
8.3.1 China Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
8.3.2 India Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
8.3.3 Japan Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
8.3.4 South Korea Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
8.3.5 Australia Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
8.3.6 South East Asia Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
8.3.7 Rest of Asia Pacific Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
9. South America Point of Care Infectious Disease Testing Market Size Outlook
9.1 Key Market Statistics, 2024
9.2 South America Point of Care Infectious Disease Testing Market Trends and Growth Opportunities
9.2.1 South America Point of Care Infectious Disease Testing Market Outlook by Type
9.2.2 South America Point of Care Infectious Disease Testing Market Outlook by Application
9.3 South America Point of Care Infectious Disease Testing Market Outlook by Country
9.3.1 Brazil Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
9.3.2 Argentina Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
9.3.3 Rest of South and Central America Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
10. Middle East and Africa Point of Care Infectious Disease Testing Market Size Outlook
10.1 Key Market Statistics, 2024
10.2 Middle East and Africa Point of Care Infectious Disease Testing Market Trends and Growth Opportunities
10.2.1 Middle East and Africa Point of Care Infectious Disease Testing Market Outlook by Type
10.2.2 Middle East and Africa Point of Care Infectious Disease Testing Market Outlook by Application
10.3 Middle East and Africa Point of Care Infectious Disease Testing Market Outlook by Country
10.3.1 Saudi Arabia Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
10.3.2 The UAE Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
10.3.3 Rest of Middle East Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
10.3.4 South Africa Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
10.3.5 Egypt Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
10.3.6 Rest of Africa Point of Care Infectious Disease Testing Market Outlook, 2021- 2032
11. Company Profiles
11.1 Leading 10 Companies
Alere
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Labs Inc
Cardinal Health
Chembio Diagnostics Inc
F. Hoffmann-La Roche Ltd
Gene POC
OJ-Bio Ltd
Ortho-Clinical Diagnostics
Quest Diagnostics Inc
Siemens Healthineers
Sight Diagnostics Ltd
Thermo Fisher Scientific Inc
Trinity Biotech
Trivitron Healthcare
11.2 Overview
11.3 Products and Services
11.4 SWOT Profile
12. Appendix
12.1 Subscription Options
12.2 Customization Options
12.3 Publisher Details

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings